(3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate
CAS No. 163041-94-9
(3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate( —— )
Catalog No. M37467 CAS No. 163041-94-9
(3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate ((3e,8z,11z)-Tetradecatrienyl Acetate) is an additive for tobacco products and a vegetable pest pheromone that can be used to capture pests in agriculture.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 37 | In Stock |
|
| 100MG | 60 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate
-
NoteResearch use only, not for human use.
-
Brief Description(3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate ((3e,8z,11z)-Tetradecatrienyl Acetate) is an additive for tobacco products and a vegetable pest pheromone that can be used to capture pests in agriculture.
-
Description(3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate ((3e,8z,11z)-Tetradecatrienyl Acetate) is an additive for tobacco products and a vegetable pest pheromone that can be used to capture pests in agriculture.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number163041-94-9
-
Formula Weight250.38
-
Molecular FormulaC16H26O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC\C=C/C\C=C/CCC\C=C\CCOC(C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
[Ala286]-Calmodulin-...
[Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) is a modified fragment of calcium/calmodulin-dependent protein kinase II that contains the active domain of CaMKII and has an alanine substitution at position 286. [Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) can be used to develop more potent CaMKII inhibitors.
-
Linzagolix
Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.
-
gp100 (457-466)
gp100 (457-466)
Cart
sales@molnova.com